Corrigendum: Melatonin and Nitrones As Potential Therapeutic Agents for Stroke

Front Aging Neurosci. 2017 May 29:9:159. doi: 10.3389/fnagi.2017.00159. eCollection 2017.

¹ Department of Toxicology and Pharmacology, Faculty of Veterinary Medicine, Complutense University of MadridMadrid, Spain.
² Paediatric Unit, La Paz University HospitalMadrid, Spain.
³ Department of Biochemistry and Molecular Biology II, Faculty of Pharmacy, Complutense University of Madrid, Ciudad UniversitariaMadrid, Spain.
⁴ Faculty of Health, Camilo José Cela UniversityMadrid, Spain.
⁵ Neuropsychopharmacology Unit, "Hospital 12 de Octubre" Research InstituteMadrid, Spain.
⁶ Laboratory of Medicinal Chemistry, Institute of General Organic Chemistry (CSIC)Madrid, Spain.
⁷ Neurovascular Research Group, Instituto de Biomedicina de Sevilla, Hospital Virgen del RocíoSevilla, Spain.
⁸ Department of Investigation, IRYCIS, Hospital Ramón y CajalMadrid, Spain.

Abstract

[This corrects the article on p. 281 in vol. 8, PMID: 27932976.].

Keywords: melatonin; neuroprotection; nitrones; oxidative stress; stroke.